Zomedica Corp, a prominent player in the veterinary biopharmaceutical sector, has been making strides in addressing the health needs of pets through innovative drug discovery and development. Operating within the broader health care sector, Zomedica is dedicated to serving veterinarians across North America, providing them with cutting-edge solutions to enhance pet health.

As of November 30, 2025, Zomedica’s stock was trading at a close price of $0.115 on the OTC Bulletin Board. This figure reflects a significant fluctuation over the past year, with the stock reaching a 52-week high of $0.158 on January 2, 2025, and a low of $0.015 on March 4, 2025. These fluctuations underscore the dynamic nature of the biopharmaceutical industry and the challenges faced by companies like Zomedica in navigating market conditions.

Despite these challenges, Zomedica maintains a market capitalization of approximately $149.1 million, indicating a robust valuation in the context of its industry. However, the company’s price-to-earnings ratio stands at -1.337, suggesting that it is currently not generating profits. This is not uncommon in the biopharmaceutical sector, where companies often invest heavily in research and development before achieving profitability.

Zomedica’s focus on drug discovery and development is pivotal to its mission of improving pet health. By concentrating on innovative solutions, the company aims to address unmet medical needs in veterinary medicine, thereby enhancing the quality of life for pets and providing veterinarians with more effective treatment options.

For those interested in learning more about Zomedica’s initiatives and developments, the company maintains an informative website at www.zomedica.com . Here, stakeholders can find detailed information about their ongoing projects, research endeavors, and strategic goals.

As Zomedica continues to navigate the complexities of the biopharmaceutical landscape, its commitment to advancing veterinary medicine remains steadfast. The company’s efforts to innovate and improve pet health are crucial in a sector that is increasingly recognizing the importance of comprehensive healthcare solutions for animals.